SynBioVen (investor - Others)
See something wrong or missing? Let us know
Offices:London
SynBioVen is an investment company backed by British politician David Lindsay Willetts and Richard Ian Kitney, a professor at London's Imperial College.
Average round investment:7.52M USD
Average number per year:2.0
Distribution:
2025 (1)2024 (1)2023 (3)2022 (3)
Generare
Mostly invests in:
United Kingdom (7)
Biotech (7)
United Kingdom (7)
Biotech (7)
See the entire list
Showing 3 of 8 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain